Validated high-conviction buyer — this insider’s opportunistic purchases fall in a cohort whose buys have historically preceded above-benchmark moves. How we measure this ↗
Director Pangalos purchases 37,453 shares at market; third open-market buy in 36 months with perfect prior timing history.
Director Menelas Pangalos is making his third open-market purchase of Absci shares in the past three years, adding nearly 20% to his existing stake. The timing is notable: the stock is trading well below its 52-week high and has experienced sharp volatility, but this purchase comes after strong recent momentum over the preceding months. Pangalos has a flawless track record with his two prior purchases at this company—both trades were followed by significant gains at the 90-day mark, suggesting strong timing judgment on this stock specifically. He is doubling down on a company that is unprofitable and facing declining revenue, but the director's consistent willingness to deploy capital at lower prices, coupled with his historical success on this ticker, indicates conviction despite the current fundamentals. This is not a casual trade: it represents meaningful capital allocation and a pattern of accumulation by someone with board-level insight into the company's trajectory.
Director Pangalos Menelas N purchased 75,095 shares of ABSI at $2.74; holdings surge 65.9% to 189.1K shares despite stock down 48.6% from 52-week high.
Pangalos Menelas N acquired 75,095 shares at $2.74 on 2026-02-27, expanding his stake by 65.9% to 189.1K shares. This is the director's second open-market purchase at Absci Corp; his prior September 2025 buy at this ticker returned +61.1% over 30 days and +27.1% over 90 days, marking a well-timed entry. However, the current acquisition arrives in a challenging context: ABSI trades at $2.57, down 48.6% from its 52-week high of $5.00, and the company faces fundamental headwinds with negative net income of $-28.7M last fiscal year and annual revenue contraction of -20.7%. The timing and scale of this purchase—combined with his successful prior entry point—merit scrutiny, yet the stock's severe recent decline and unprofitable operations mean any conviction signal must be weighed against deteriorating business fundamentals.
Director Pangalos purchased 95,785 shares at $2.66; holdings now 113,960 shares (+527.0% vs prior), amid -20.7% revenue decline and $-30.6M annual net loss.
Director Pangalos Menelas N acquired 95,785 shares for $254,788.10, increasing his position by 527.0% to 113,960 shares total. This substantial absolute purchase occurs in a company generating only $593,000 in latest-quarter revenue while reporting a full-year net loss of $-30.6M and experiencing -20.7% annual revenue decline. The stock has declined -57.2% from its 52-week high of $5.82 to the current $2.49 price. The magnitude of this position increase and the timing relative to severely deteriorated fundamentals warrant examination of whether this reflects insider confidence in operational turnaround prospects or other material considerations not yet disclosed in public filings.
